Join host Lindsey Smith and other Osmosis team members for a global conversation about improving health and healthcare with prominent figures in education and healthcare innovation such as Chelsea Clinton, Mark Cuban, Dr. Ashish Jha, Dr. Eric Topol, Dr. Vivian Lee and Sal Khan, as well as senior leaders at organizations such as the CDC, National Institutes of Health, Johns Hopkins University, WHO, Harvard University, NYU Langone and many others.
Join us on this special episode as we start a series of conversations with the winners of the Osmosis from Elsevier 2022 Raise the Line Faculty Awards which recognize the inspirational educators who …
Regular listeners to Raise the Line know that research into rare diseases should matter to everybody because it has led to treatments for much more common conditions that have improved and saved mill…
Lucy Landman is one of only a few children known worldwide to have a genetic disorder called PGAP3, in which a single missing gene can cause seizures and severe physical and cognitive limitations. Lu…
Eighty percent of rare diseases are caused by genetic mutations, which is why many of our recent guests have highlighted the importance of pursuing gene therapies as potential treatments and cures. T…
“Burnout to me is about losing control, not overwork. It's about being unable to solve problems, and problems beginning to stack up with no end in sight.” Today’s Raise the Line guest Justin Welsh ea…
“The qualities of a provider that were envisioned fifty years ago are completely different from what the world needs for tomorrow. It’s completely different,” insists Dr. Abebe Bekele, who is entrust…
“Our rare disease community is looking to solve for many different types of policy barriers because we have a very diverse patient community,” says Annie Kennedy, who was drawn to the rare disease is…
“In about three weeks, I went from a completely normal thirty-year-old to somebody with a heart transplant. It was crazy,” says Dr. Alin Gragossian, who shares her remarkable experience on this editi…
There are so many choices to make as an undergrad in med school: selecting which medical field to go into; whether to go down the academic path; and how to use your knowledge and skills to find succe…
A singing guest! A poetic chat bot! This special episode of Raise the Line features those unusual artistic highpoints along with the substantive and interesting conversation you always get with host…
“There's a real diversity of jobs available that folks don’t always think about initially when they think about going into healthcare,” says Marc Cummings, the President and CEO of Life Science Washi…
“With psychedelics right now, there's a lot of hype around the compound, which is somewhat important, but Sunstone Therapies is really founded on the belief that the delivery is more important than t…
Our guest on this episode of Raise the Line, Dr. Githinji Gitahi, ended up in the medical field because he’s always had a nagging need for social justice. “That was a place that I found where social …
Why is it that Hispanics make up 20% of the U.S. population, but only 6% of the physician workforce? Well, Dr. Pilar Ortega, founding president of the National Association of Medical Spanish and co-f…
“Patients don’t understand how little we actually know in medicine. I'm not sure if doctors understand this, either,” says Dr. Lisa Sanders, an associate professor at Yale School of Medicine who is p…
“In medical school, you don't learn about leadership. You don't learn about what skills are required to make large-scale strategic decisions that can impact your patients,” says Nita Gombakomba, who …
“I know it's hard for people to think about holding on if they're in despair, but there's the possibility of healing coming ahead. Don’t give up hope,” says Dr. Rick Doblin, who has devoted his caree…
The growth in skepticism about science that was fueled by disinformation during the pandemic has been a frequent topic on Raise the Line, with many insightful guests from medicine and academia offeri…
“It's still early days in the application of all this technology relative to its long-term potential, but even so, it's already producing some big wins for patients,” says Dr. Matthew Might, whose im…
We welcome one of the nation's most respected health and health policy thought leaders to Raise the Line on this episode. Susan Dentzer’s remarkable career includes many years of reporting on health…